[The concept of innovative drugs rebounded with shock and Dezhan Health had 2 boards in 3 days] On September 7th, the concept of innovative drugs rebounded with shock and 2 boards in 3 days. Dezhan Health had 2 boards in 3 days. Haooubo rose by nearly 10%. Qianjin Pharmaceutical, Wanbang Pharmaceutical, Borui Pharmaceutical, Harbin Pharmaceutical Co., Ltd., etc. followed suit. In terms of news, the National Medical Insurance Administration made it clear at a press conference held by the State Council Information Office on September 4 that during the “15th Five-Year Plan” period, the medical insurance drug catalog will continue to be adjusted every year to include more innovative drugs in major disease fields such as tumors, chronic diseases, rare diseases, and children for reimbursement. At the same time, we will promote the national unification of the reimbursement catalog for medical services and consumables and narrow regional differences.